154023-65-1

Basic information

• Product Name: Benzoic acid, 3,3'-carbonylbis[5-chloro-6-methoxy-, dimethyl ester
• CAS NO: 154023-65-1
• Molecular Formula: C19H16Cl2O7
• Molecular Weight: 427.238
• Mol File: 154023-65-1.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 3,3'-carbonylbis[5-chloro-6-methoxy-, dimethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 3,3'-carbonylbis[5-chloro-6-methoxy-, dimethyl ester(154023-65-1)
• EPA Substance Registry System: Benzoic acid, 3,3'-carbonylbis[5-chloro-6-methoxy-, dimethyl ester(154023-65-1)

Safety Data

• Hazardous Substances Data: 154023-65-1(Hazardous Substances Data)

Upstream product

• 154023-64-0 3,3'-dicarbomethoxy-5,5'-dichloro-4,4'-dimethoxydiphenylmethane 
• 1829-32-9 3-Chloro-2-hydroxybenzoic acid 
• 128626-47-1 3,3'-dichloro-5,5'-dicarboxy-4,4'-dihydroxydiphenylmethane 

Downstream Products

• 183487-85-6 tetra(3-chloro-4-methoxy-5-methoxycarbonylphenyl)ethylene 
• 207743-13-3 3',3''-dichloro-4',4''-dimethoxy-5',5''-bis(methoxycarbonyl)-1,1-diphenyl-6-[(tert-butyldiphenylsilyl)oxy]-1-hexene 
• 207743-09-7 3',3''-dichloro-4',4''-dimethoxy-5',5''-bis(methoxycarbonyl)-1,1-diphenyl-4-[(tert-butyldiphenylsilyl)oxy]-1-butene 
• 204864-54-0 methyl-3',3-dichloro-4',4-dimethoxy-5',5-bis(methoxycarbonyl)-6,6-diphenylhexenoate 
• 185384-88-7 5α-3β-[5',5'-(3'',3'''-dicarbomethoxy-5'',5'''-dichloro-4'',4'''-dimethoxydiphenyl)-4'-pentenyl]cholestane 
• 159499-82-8 5α-3β-[3',3'-(3'',3'''-dicarbomethoxy-5'',5'''-dichloro-4'',4'''-dimethoxydiphenyl)-2'-propenyl]cholestane 
• 185384-96-7 5α-6β-[4',4'-(3'',3'''-dicarbomethoxy-5'',5'''-dichloro-4'',4'''-dimethoxydiphenyl)-3'-butenyl]cholestane 
• 159500-10-4 4-[(tert-butyldimethylsilyl)oxy]-3',3''-dichloro-4',4''-dimethoxy-5',5''-bis(methoxycarbonyl)-1,1-diphenyl-1-butene 
• 159500-20-6 1,1-bis<5'-chloro-4'-methoxy-3'-(methoxycarbonyl)phenyl>-1-heptene 

Relevant articles and documents

Investigation of the alkenyldiarylmethane non-nucleoside reverse transcriptase inhibitors as potential cAMP phosphodiesterase-4B2 inhibitors

The alkenyldiarylmethanes (ADAMs) are currently being investigated as non-nucleoside HIV-1 reverse transcriptase inhibitors (NNRTIs) of potential value in the treatment of HIV infection and AIDS. During the course of these studies, a number of ADAM analog

HETEROBIFUNCTIONAL COMPOUNDS FOR SELECTIN INHIBITION

Compounds and methods are provided for modulating in vitro and in vivo processes mediated by selectin binding. More specifically, selectin modulators and their use are described, wherein the selectin modulators that modulate (e.g., inhibit or enhance) a selectin-mediated function comprise glycomimetics linked to a compound, for example a member of a class of compounds termed BASAs (Benzyl Amino Sulfonic Acids) or a member of a class of compounds termed BACAs (Benzyl Amino Carboxylic Acids).

Studies directed toward a more potent cosalane pharmacophore: Synthesis of a substituted tetraphenylethylene which inhibits the cytopathic effect of HIV-1

Tetra(3-carboxy-5-chloro-4-hydroxyphenyl)ethylene (6) was prepared by a modified McMurry coupling of 3,3′-dichloro-5,5′-di(methoxycarbonyl)-4,4′- dimethoxybenzophenone (9) in the presence of zinc and titanium tetrachloride in refluxing tetrahydrofuran, fo